Francisco Carlos Costa Darrieux
Overview
Explore the profile of Francisco Carlos Costa Darrieux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dos Santos Sousa I, Chokr M, Melo S, Pisani C, Hardy C, de Moura L, et al.
J Interv Card Electrophysiol
. 2024 Jun;
67(9):1981-1991.
PMID: 38833098
Background: Catheter ablation of parahisian accessory pathways (PHAP) are challenging due to their proximity to the normal conduction system. Retrospective studies suggest that cryoablation has a better safety profile but...
2.
Marcatto L, Boer B, Sacilotto L, Olivetti N, Darrieux F, Scanavacca M, et al.
J Thromb Thrombolysis
. 2020 Sep;
51(4):1043-1049.
PMID: 32974757
Poor adherence to warfarin treatment is a contributor to poor quality of treatment, which increases the risk of bleeding and thromboembolic events. This study aims to evaluate the impact of...
3.
Marcatto L, Sacilotto L, Camargo Tavares L, Souza D, Olivetti N, Strunz C, et al.
Front Pharmacol
. 2020 Aug;
11:1056.
PMID: 32765269
Background: Warfarin is the most common oral anticoagulant drug, especially in low-income and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or when warfarin is the...
4.
Oliveira A, Neves I, Sacilotto L, Olivetti N, Dos Santos-Paul M, Montano T, et al.
J Am Heart Assoc
. 2019 Jul;
8(15):e012361.
PMID: 31319747
Background Brugada syndrome and long-QT syndrome may account for at least one third of unexplained sudden cardiac deaths. Dental care in patients with cardiac channelopathies is challenging because of the...
5.
Marcatto L, Sacilotto L, Camargo Tavares L, Facin M, Olivetti N, Strunz C, et al.
Front Pharmacol
. 2018 Oct;
9:1052.
PMID: 30298004
Thromboembolic events are associated with high mortality and morbidity indexes. In this context, warfarin is the most widely prescribed oral anticoagulant agent for preventing and treating these events. This medication...
6.
Marcatto L, Sacilotto L, Bueno C, Facin M, Strunz C, Darrieux F, et al.
BMC Cardiovasc Disord
. 2016 Nov;
16(1):224.
PMID: 27855643
Background: Time in therapeutic range (TTR) is a measurement of quality of warfarin therapy and lower TTR values (<50%) are associated with greater risk of thromboembolic and bleeding events. Recently,...